Literature DB >> 19829008

Evaluation of Megacell MEM as a storage medium for corneas destined for transplantation.

Valerie A Smith1, Terrell Johnson.   

Abstract

PURPOSE: Gibco's Minimum Essential Medium with Earle's salts and HEPES supplemented with glutamine, antibiotics (EB MEM) and 2% foetal calf serum (FCS) is used in European eye banks to store corneas. Although FCS is important to endothelial cell survival in this medium, it is a potential biohazard. Megacell MEM, formulated to reduce the FCS requirement of cells by a factor of 5, has therefore been evaluated as a corneal storage medium.
METHODS: Corneal stromal and epithelial cells were incubated in Megacell MEM (serum-free or 2% FCS) to assess their viability in these media. Endothelial cell densities of paired corneas held in either EB MEM 2% FCS or Megacell MEM (serum-free or 2% FCS) were measured over 5 weeks. Discs subsequently punched from the centre of these corneas were weighed, dried and reweighed to determine hydration levels.
RESULTS: Both corneal stromal and epithelial cells proliferated in Megacell MEM 2% FCS. Relative to EB MEM, 2% FCS Megacell MEM prolonged the viability of corneal endothelial cells and improved their morphological appearance, irrespective of whether it contained FCS or not. This was independent of corneal swelling.
CONCLUSION: Serum-free Megacell MEM is a better storage medium than EB MEM 2% FCS for corneas destined for transplantation. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19829008     DOI: 10.1159/000246574

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  2 in total

1.  Identification and evaluation of a thinning agent compatible with MegaCell DCS, an animal product-free corneal storage medium.

Authors:  Valerie A Smith; Terrell K Johnson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-12       Impact factor: 3.117

2.  Comparisons of Cornea Cold, a New Corneal Storage Medium, and Optisol-GS.

Authors:  Joanne W Ho; Hoon Jung; Mimi Chau; James A Kuchenbecker; Michael Banitt
Journal:  Cornea       Date:  2020-08       Impact factor: 3.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.